{"id":"W2978886033","doi":"10.1093/annonc/mdz407","title":"Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial","year":2019,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":194,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Institut National Du Cancer; Fondation ARC pour la Recherche sur le Cancer; CNIB","keywords":"Crizotinib; Medicine; Anaplastic lymphoma kinase; ROS1; Oncology; Internal medicine; Lung cancer; Clinical trial; Cancer; Adenocarcinoma","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001194998,0.00134906,0.002368305,0.0002097323,0.0002865613,0.001131082,0.0004756736,0.0008935197,0.001993652],"category_scores_gemma":[0.00140095,0.0002388578,0.00160734,0.0003756059,0.00048282,0.0006847793,0.0002964629,0.002702421,0.0005920085],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001445515,"about_ca_system_score_gemma":0.0009612284,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002569618,"about_ca_topic_score_gemma":0.009382551,"domain_scores_codex":[0.9996289,0.0001457894,0.00001950372,0.00006603451,0.00005171328,0.00008796137],"domain_scores_gemma":[0.999548,0.00008806689,0.00009127889,0.00003564711,0.00004910634,0.0001879031],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7515711,0.003849746,0.009032331,0.002455285,0.006189176,0.0003144807,0.0001934869,0.003513554,0.02078211,0.0006549176,0.01962373,0.1818201],"study_design_scores_gemma":[0.837628,0.08751961,0.04064545,0.0002787841,0.004885674,0.0007772103,0.000175005,0.00269066,0.003689401,0.001234185,0.02039349,0.00008255371],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.952445,0.03191244,0.0005193776,0.00287817,0.0004962491,0.0008523078,0.003417861,0.0001675642,0.007311],"genre_scores_gemma":[0.9691038,0.01494609,0.001036509,0.00221479,0.0003546575,0.0006779705,0.006394804,0.00005422995,0.005217201],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002569618,"threshold_uncertainty_score":0.01048803,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08230904271557742,"score_gpt":0.4842450247288527,"score_spread":0.4019359820132753,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}